Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Henry Schein HSIC in the last three months. The table below summarizes their recent ratings ...

Dental and medical products company Henry Schein (NASDAQ:HSIC) in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts ...

Henry Schein, Inc. HSIC is expected to release first-quarter 2024 results on May 7 before the opening bell. The company posted adjusted earnings per share (EPS) of 66 cents in the last reported ...

Feb 25 (Reuters) - Henry Schein (HSIC.O), opens new tab forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein (NASDAQ:HSIC) in the last three months. The table below offers a condensed view ...